TV A19 Pill - yellow oval, 15mm
Pill with imprint TV A19 is Yellow, Oval and has been identified as Progesterone 200 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Progesterone is used in the treatment of Progesterone Insufficiency; Endometrial Hyperplasia, Prophylaxis; Perimenopausal Symptoms; Amenorrhea; Uterine Bleeding and belongs to the drug class progestins. oral formulations: There is no proven risk in humans during pregnancy. excluding oral formulations: FDA has not classified the drug for risk during pregnancy. Progesterone 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TV A19
Progesterone
- Imprint
- TV A19
- Strength
- 200 mg
- Color
- Yellow
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Rx and/or OTC
- Drug Class
- Progestins
- Pregnancy Category
- B - No proven risk in humans - oral formulations, N - Not classified - excluding oral formulations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-5354 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
glycerin,
soya lecithin,
peanut oil,
propylene glycol,
polyvinyl acetate phthalate,
polyethylene glycol 400,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about progesterone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (77)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: progestins
- Breastfeeding
Patient resources
- Progesterone drug information
- Progesterone vaginal
- Progesterone Capsules
- Progesterone Vaginal 8% Gel
- Progesterone Vaginal Insert
Other brands
Prometrium, Endometrin, Crinone, Prochieve
Professional resources
- Progesterone monograph
- Progesterone (Advanced Reading)
- Progesterone (FDA)
- Progesterone Capsule (FDA)
- Progesterone Injection (FDA)
Other brands
Prometrium, Endometrin, Milprosa
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.